DENISE CRAWFORD: Open Payments
NPI 1649630153 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$938 in 33 payments from 7 companies in 2025. Trend: 2023 $673 · 2024 $1,629 · 2025 $938
Food & beverage: $867Education: $71
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $307 |
| Otsuka America Pharmaceutical, Inc. | 7 | $198 |
| Alkermes, Inc. | 5 | $198 |
| Teva Pharmaceuticals USA, Inc. | 6 | $140 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| Neurocrine BioSciences, Inc. | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: VRAYLAR, ABILIFY MAINTENA, LYBALVI, ARISTADA, AUSTEDO XR, COBENFY, REXULTI, INGREZZA.
Industry payments across OH — which companies pay providers there.
